COMING SOON Paying for Cures Toolkit update in early ’22 After the holiday FoCUS will release a major update to the toolkit, including updates to the Pipeline and Individual Indication worksheets … Read More
LEAPS Monthly Recap: December 2021
DESIGN LAB REPORT LEAPS Design Lab advances pilot projects At the November 30 and December 1 Design Lab participants shaped the designs for three pilots to launch in 2022. … Read More
LEAPS Monthly Recap: October 2021
NEW MEMBER Flatiron Health joins LEAPS Project This month, Flatiron Health, the clinical and science data healthtech company dedicated to helping cancer centers thrive and deliver better care for patients today … Read More
FoCUS Monthly Recap: October 2021
NEW SOLUTIONS Financing solutions emerging from the market: A FoCUS survey and analysis How are market leaders responding to the barriers of cost and uncertainty associated with cell and gene therapies … Read More
The NEWDIGS Initiative at MIT welcomes Flatiron Health as a new collaborator for the LEAPS Project
CAMBRIDGE, MA October 29, 2021 – Flatiron Health®, a world leader in transforming patients’ real-life experiences into knowledge to help accelerate improvements in cancer care and treatments, has joined the Massachusetts Institute … Read More
FoCUS Monthly Recap: September 2021
NEW RESOURCES Self-Insured Employers Workshop shares practical advice for covering cell and gene therapies In June FoCUS hosted a workshop for self-insured employers to help them understand the challenges and … Read More
LEAPS Monthly Recap: September 2021
NEW RESEARCH Precision for whom? Partnering with patients to ensure that Precision Medicine targets what matters Despite decades of growth and adaptation in patient engagement, knowing or being able to … Read More
Self-Insured Employers Workshop shares practical advice for covering cell and gene therapies
In June FoCUS hosted a workshop for self-insured employers to help them understand the challenges and potential solutions presented by new cell and gene therapies. In our event archive you … Read More
NEWDIGS + National Pharmaceutical Council in Health Affairs: Medicaid Best Price Volatility Could Inhibit Payment Innovation
Value-based payment (VBP) arrangements (also known as outcomes- or performance-based contracting) for drugs transform drug pricing from paying for expected benefits projected from clinical trials to paying for actual benefits … Read More
Upcoming book highlighting NEWDIGS Design Labs now available for pre-order
The LEAPS Project of the MIT NEWDIGS initiative is actively soliciting Use Cases for our workstream focused on methods innovation associated with “Integrating Evidence Using Meta-Analytic Approaches.” This methodology is … Read More